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Objective: Endovascular treatment of thoracic aortic disease may be associated with severe neurologic complications. The
current study used the data of a multicenter registry to assess of the incidence and the risk factors for paraplegia or
paraparesis and intracranial stroke.
Methods: The European Collaborators on Stent/Graft Techniques for Aortic Aneurysm Repair (EUROSTAR) database
prospectively enrolled 606 patients. Thoracic pathologies with urgent or elective presentation, which included degener-
ative aneurysm in 291, aortic dissection in 215, traumatic rupture in 67, anastomotic false aneurysm in 24, and infectious
or nonspecified disorders in 9. Study end points included evidence of perioperative spinal cord ischemia (SCI) or stroke.
Univariate analysis and multivariate regression models were used to assess the significance of clinical factors that
potentially influenced the occurrence of neurological sequelae.
Results: Paraplegia or paraparesis developed in 15 patients (2.5%) and stroke in 19 (3.1%); two patients had both
complications. At multivariate regression analysis, independent correlation with SCI was observed for four factors: (1)
left subclavian artery covering without revascularization (odds ratio [OR], 3.9; P .027), (2) renal failure (OR, 3.6; P
.02), (3) concomitant open abdominal aorta surgery (OR, 5.5; P  .037) and (4) three or more stent grafts used (OR,
3.5; P  .043). In patients with perioperative stroke, two correlating factors were identified: (1) duration of the
intervention (OR, 6.4; P  .0045) and (2) female sex (OR, 3.3; P  .023). A neurologic complication (paraplegia or
stroke) developed in 8.4% of the patients in whom left subclavian covering was required compared with 0% of patients
with prophylactic revascularization (P  .049).
Conclusion: Perioperative paraplegia or paraparesis was significantly associated with blockage of the left subclavian artery
without revascularization. The clinical significance of this source of collateral perfusion of the spinal cord had not been
confirmed previously. Intracranial stroke was associated with lengthy manipulation of wires, catheters, and introducer
sheaths within the aortic arch, reflected by a longer duration of the procedure. (J Vasc Surg 2007;46:1103-11.)Conventional thoracic aortic surgery is primarily used
in patients in relatively goodmedical condition, and even in
centers of excellence, the first-month mortality for the
descending thoracic aorta is considerable, ranging from 6%
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doi:10.1016/j.jvs.2007.08.020to 13%.1-4 In contrast, endovascular treatment of thoracic
aortic aneurysms, dissections, traumatic lesions, and other
disorders has been demonstrated to provide a relatively
low-risk treatment for these conditions.5,6 Although endo-
vascular repair of thoracic aortic disease now has become a
widespread treatment option, the risk of complications has
not been eliminated. Neurologic adverse events do occur
after endografting of the thoracic aorta, with a mean inci-
dence of 2.2% for perioperative paraplegia and of 2.7% for
intercranial stroke.5,7-10
The current study includes an analysis of a large
database of endovascular repair of various thoracic aortic
pathologies, the European Collaborators on Stent/Graft
Techniques for Aortic Aneurysm Repair (EUROSTAR)
Registry. The perioperative incidence of the two main
neurologic complications of perioperative paraplegia and
intercranial stroke and the relative influence of different
risk factors at baseline and during the procedures were
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cussed. Finally, the survival of patients after neurologic
events was assessed.
METHODS
The data on which the present report is based come from
the EUROSTAR Thoracic Registry. This voluntary observa-
tional study was established in 2000. It is linked in terms of
administration and protocol with the EUROSTAR Registry
of Endovascular Repair of Abdominal Aortic Aneurysms. Ag-
gregated data from the EUROSTAR and UK Thoracic Reg-
istry, which are compatible registries, were published in
2004.11
This analysis was based on 606 patients with aneurysm
or dissection in the thoracic aorta who underwent endovas-
cular repair between July 2000 and July 2006. Only pa-
tients who had been prospectively entered in the registry
were considered. Ten patients with thoracic aortic abnor-
malities classified as penetrating ulcers without coexisting
dissection or aneurysm were excluded from the assessment
because this number was considered too small for meaning-
ful conclusions.
Patients were recruited from 58 European institutions
(Appendix 1, online only). Patients received the following
commercially available devices approved for use in coun-
tries of the European Community (CE approved): Talent
(Medtronic/AVE, Minneapolis, Minn) in 386, TAG-
Excluder (W. L. Gore & Assoc, Flagstaff, Ariz) in 119,
Zenith TX2 (William Cook Europe, Bjaeverskov, Den-
mark) in 39, Valiant (Medtronic/AVE, Minneapolis,
Minn) in 28, Endofit (Endomed, Phoenix, Ariz) in 12,
AneuRx (Medtronic/AVE,Minneapolis, Minn) in 4, Relay
(Bolton Medical, Sunrise, Fla) in 2, and 16 other or un-
known devices.
Emergency procedures were defined arbitrarily as those
that require treatment7 days of first presentation, except
for dissections, in which the conventional period of 2 weeks
for discrimination between acute or chronic condition was
followed.
Collected baseline data included comorbidities, fitness
for open surgery as classified according to the American
Society of Anesthesiology (ASA), aneurysm anatomy, and
operative details. Aneurysmatic lesions were categorized
according to their primary anatomic location and extend in
lesions within (1) the ascending thoracic aorta or arch, (2)
proximal, (3) middle, (4) distal one-third of the descending
thoracic aorta, and (5) lesions in three or more of these
segments. Dissections were categorized similarly according
to the site of the primary intimal tear.
Conduct of the thoracic endograft procedures, adjunct
operations, and perioperative monitoring was at the discre-
tion of the managing physicians. Covering of different
levels of intercostal arteries was judged on intraoperative
fluoroscopy combined with assessment of the preoperative
computed tomography (CT) study.
Data were collected on case record forms before Octo-
ber 2004 and thereafter entered by the participants onto
the database by using the EUROSTARWeb site. Outcomereporting adhered to the guidelines from the Ad Hoc
Committee for Standardized Reporting Practices in Vascu-
lar Surgery of the Society for Vascular Surgery/American
Association for Vascular Surgery.12 Groups that were com-
pared consisted of patients with postoperative symptoms of
spinal cord ischemia (SCI), those with stroke or neurologic
event, and patients without neurologic event. Definitions
and incidence rates of technical success, follow-up meth-
ods, and data on the entire study cohort and subgroups are
presented in Appendix 2 (online only).13-24
Data were presented as means and ranges or standard
deviations. Odds risk ratios (OR) and 95% confidence
intervals (95% CI) were calculated to correlate patient
characteristics and operative technical factors with the main
outcome events in this study. Multivariate logistic regres-
sion was performed to assess the independent correlations
of potential risk factors and outcomes were presented as P
values, OR, and 95% CI.
Variables entered in the multivariate model were se-
lected because of significant differences between subgroups
at univariate comparison or because of clinical consider-
ations. Death occurring 30 days of the initial procedure
or during the hospital admission period was categorized as
operative death and death occurring30 days as late death
(results presented in Appendix 2, online only).
Statistical significance of differences in proportions was
determined with 2 tests or Fisher tests and differences in
continuous parameters with the Mann-Whitney test. The
Kaplan-Meier method was used to determine cumulative
survival. P  .05 was considered statistically significant.
The data were analyzed with SAS 8.02 software (SAS
Institute Inc, Cary, NC).
RESULTS
The study cohort consisted of 606 patients, of whom
471 (77.7%) were men. Mean patient age was 63.2 years
(range, 13 to 91 years, Table I). Degenerative aneurysm
was present in 291 patients, aortic dissection in 215, anas-
tomotic false aneurysm in 24, and traumatic aortic injury in
67. Two patients with mycotic aneurysm were treated by
thoracic stent grafts, and in seven, the diagnosis was not
clearly recorded. Penetrating ulcer was diagnosed in 30
patients (5%), usually in association with aortic dissection,
but was a degenerative aneurysmatic aorta in 14. The
maximum diameter in patients with aneurysmatic lesions
(excluding patients with dissection without aneurysmatic
dilatation) was 62.7  15.3 mm (range, 29 to 120 mm).
Disorders were chronic in 379 patients and acute in 205;
whether the disease was chronic or acute was not clear in 22
patients.
Stent grafts were a mean length of 12.4  3.7 cm, and
1.8  0.97 stent grafts were used per patient. Data on
length of overlap zones between devices and overall cov-
ered aortic length were not available. In 78 patients (13%),
there was involvement of the aortic arch or ascending
thoracic aorta. The proximal one-third segment of the
descending thoracic aorta was involved in 393 patients
(65%), the middle one-third in 240 (40%), the distal one-
cular S
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thoracic aorta in 69 (11%).
During the first month after the thoracic stent graft
procedure, neurologic complications were observed in 32
patients. Of these, 15 patients had evidence of paraplegia or
paraparesis and constituted the group with postoperative
SCI. Two patients, one with temporary sensory loss in the
lower extremities and one with minimal symptoms de-
scribed as “possibly caused by spinal cord infarction,” were
not included in the SCI group because of the diagnosis was
uncertain. Symptoms of cerebrovascular accidents were
present after the stent graft procedure in 19 patients, and
they constituted the group with postoperative stroke. A
combination of SCI and stroke symptoms was observed in
two patients, and they were included in both study groups.
Excluded from the group with stroke were six patients with
temporary cerebral symptoms, including three with obvi-
ous transient ischemic attacks and three with atypical symp-
toms. During the first month, 574 patients had no symp-
toms of paraplegia/paraparesis or stroke. General outcome
events in groups with and without neurologic events, in-
cluding technical success rates of procedures, morbidity,
early and late mortality (Appendix 2 Fig, online only), and
a comparison with previous publications13-24 is presented
in Appendix 2 (online only).
Patient factors, procedural details, and correlation
with neurologic complications. Patients with postoper-
ative stroke were significantly older, more frequently
women, and less frequently known with preoperative hy-
pertension. Paraplegic or paraparetic patients had more
frequently a high ASA classification (class IV) and renal
function impairment (Table I). In patients with SCI, de-
Table I. Patient characteristics and comorbidity
With paraplegia
(n  15)
Patient factors†
Age, mean (range) 66.0 (37-83)
Male 14 (93.3)
ASA IV 6 (40.0)§
ASA III 10 (66.7)
Previous MI/AP/HF 5 (33.3)
Previous PTCA/CABG 1 (6.7)
Diabetes 1# 2 (13.3)
Hypertension 1# 12 (80.0)
Renal function impairment (SVS/ISCVS
score 1)# 7 (46.7)§
Cardiac disease 1# 6 (40.0)
Previous thoracic aortic procedures 0 (0.0)
Unfit for open thoracic repair 6 (40.0)
OR,Odds ratio;CI, confidence interval;ASA, American Society of Anesthes
percutaneous transluminal coronary angioplasty; CABG, coronary artery b
Vascular Surgery.
*P values for three groups. In text, P values are for a study group vs contro
†Data are presented as number (%) unless indicated otherwise.
‡Age dichotomized at 65 years was significantly higher in stroke patients.
§Statistically significant from control group (other patients).
#Indicates Society for Vascular Surgery/International Society for Cardiovasgenerative aneurysm as the primary thoracic aortic pathol-ogy was more frequently observed than in other patients.
No other significant differences were observed in the dis-
tribution of aortic disorders or the prevalence of acute or
chronic presentation in the two groups with neurologic
events compared with the other patients (Table II). Local-
ization of the aortic pathology demonstrated a higher
incidence of aortic arch or ascending thoracic aorta involve-
ment in patients with stroke compared with patients with-
out neurologic events: six patients (32%) vs 83 (14%),
respectively (OR, 2.61; 95% CI, 1.02 to 6.70; P  .040).
No difference was observed between groups with and
without neurologic events in type of anesthesia (regional or
local anesthesia was used in 7.1% of patients in the entire
cohort), induced hypotension or use of adenosine for car-
diac cessation (43%), or use of iliac artery, abdominal aorta,
or surgical implanted prostheses for access to the thoracic
aorta (13%). The duration of the procedure was signifi-
cantly longer in patients with stroke at 195.6  152.6 vs
124.4 78.6 minutes for patients with160 minutes vs a
shorter procedural time (OR, 3.67; 95% CI, 1.46 to 9.25;
P  .003). From one to seven stent grafts were used, and
significantly more stent grafts were used in patients with
paraplegia or paraparesis, with three or more device com-
ponents in 53% vs 19% in controls (OR, 4.94; 95% CI, 1.76
to 13.92; P  .0009).
The frequency of covering of intercostal arteries at the
T9, T10, T11, and T12 levels was similar in patients with
stroke and without neurologic events. However, intercostal
arteries at the T10 level were more frequently occluded in
patients with SCI compared with those without neurologic
events (6 patients [40%] vs 102 [18%], respectively; P 
ith stroke
(n  19)
Other patients
(n  574) P* OR (95% CI)
.7 (59-82)‡ 62.9 (13-91) .008‡ 5.89 (1.35-25.75)‡
11 (57.9)§ 448 (78.1) .0388 0.39 (0.15-0.98)
5 (26.3) 96 (16.7) .0187 3.32 (1.15-9.54)
9 (47.4) 268 (46.7)
5 (26.3) 143 (24.9)
0 (0.0) 55 (9.6)
1 (5.3) 57 (9.9)
8 (42.1)§ 399 (69.5) .0113 0.32 (0.13-0.81)
4 (21.1) 101 (17.6) .0041 4.10 (1.45-11.56)
7 (36.8) 201 (35.0)
0 (0.0) 64 (11.2)
3 (15.8) 185 (32.2)
sts;MI,myocardial infarction;AP, angina pectoris;HF, heart failure; PTCA,
graft; SVS/ISCVS, Society for Vascular Surgery/American Association for
p.
urgery class 1.W
71
iologi
ypass
l grou.034, OR, 2.98; 95% CI, 1.04 to 8.55).
205 a
had co
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occurrence of postoperative neurologic deficits were as-
sessed in detail. The left subclavian artery (LSA) was
covered by the device in 159 patients (26%), of whom 40
were additionally treated with a LSA revascularization by
transposition or bypass, and 119 of these patients did not
undergo LSA revascularization (Table III). The inci-
dence of LSA occlusion without revascularization was
significantly higher in the study group with paraplegia/
paraparesis than in other patients at 40% vs 19% (OR,
2.82; 95% CI, 1.00 to 8.08). The frequency of LSA
covering was comparable in stroke patients and others.
However, the rate of combined neurologic complica-
Table II. Classification of thoracic aortic pathologies
Pathology
With paraplegia (n  15),
No. (%)*
Degenerative aneurysm 11 (73.3)†
Chronic 8 (72.7)
Acute 3 (27.3)
Unknown 0 (0)
Dissection 3 (20.0)
Chronic 0 (0)
Acute 3 (100)
Traumatic rupture 1 (6.7)
Chronic 0 (0)
Acute 1 (100)
Unknown 0 (0)
False anastomotic aneurysm 0 (0)
Chronic 0 (0)
Acute 0 (0)
Infectious complications 0 (0)
Chronic 0 (0)
Acute 0 (0)
Unknown etiology 0 (0)
All etiologies‡
Chronic 8 (53.3)
Acute 7 (46.7)
Unknown 0 (0)
*Percentage calculated in regard to the number of patients in each specific
†Statistically significant from control group (other patients): Odds ratio, 3.1
‡Total number of patients with chronic, acute or unknown etiology was 379,
had SCI and stroke combined).
Table III. Left subclavian artery covering and correlation
Paraplegia (
No. (%
With LSA artery covering 6 (40.0
Without transposition/bypass 6 (40.0
With transposition/bypass 0
Stroke (n
N (%
With LSA artery covering 5 (26.3
Without transposition/bypass 5 (26.3
With transposition/bypass 0 (0)
LSA, Left subclavian artery; NS, not significant.
*One patient with left subclavian artery covering without revascularizationtions (paraplegia or stroke) in the group with LSA cov-ering without revascularization was 8.4% (10 of 119),
which compared unfavorably with the 0% rate in 40
patients with revascularized LSA covering (P  .049).
Simultaneous open repair of the abdominal aorta was
significantly more frequently performed in the SCI
group (n  3, 20%) compared with other patients (n 
18, 3.1%; OR, 7.96; 95% CI, 2.06 to 30.68; P  .0003).
Multivariate analysis of risk factors for spinal cord
ischemia and stroke. Multivariate regression analysis
demonstrated an independent correlation of SCI and the
variables of the number of stent grafts used, covering of the
LSA without revascularization, renal function impairment,
and simultaneous abdominal aortic repair (Table IV). Of
With stroke (n  19),
No. (%)*
Other patients (n  574),
No. (%)
11 (57.9) 270 (47.0)
7 (63.6) 209 (77.4)
3 (27.3) 48 (17.8)
1 (9.1) 13 (4.8)
7 (36.8) 206 (35.9)
3 (42.9) 110 (53.4)
4 (57.1) 96 (46.6)
1 (5.3) 65 (11.3)
1 (100) 26 (40.0)
0 (0) 38 (58.5)
0 (0) 1 (1.5)
0 (0) 24 (4.2)
0 (0) 15 (62.5)
0 (0) 9 (37.5)
0 (0) 2 (0.4)
0 (0) 2 (100)
0 (0) 0 (0)
0 (0) 7 (1.2)
11 (57.9) 361 (62.9)
7 (36.8) 192 (33.5)
1 (5.3) 21 (3.7)
ogy group for each study group.
% confidence interval, 1.00 to 9.84; P  .0441.
nd 22 respectively in the entire cohort (accounting for the two patients who
neurologic event
5), Other (n  591),
No. (%) P
153 (25.9) .2199
113 (19.1) .0444
40 (6.8) .2971
Other (n  587)
N (%)
154 (26.2) .9937
114 (19.4) .4565
40 (6.8) .2954
mbined paraplegia and stroke.pathol
0; 95with
n  1
)
)
)*
19),
)
)
)*the four variables with significant correlation in this model,
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three or more in eight.
In patients with stroke, two factors had an independent
significant correlation: the duration of the stent graft pro-
cedure and female sex (Table V). None of the other tested
variables had an independent correlation with stroke.
DISCUSSION
The incidence of paraplegia after open surgical repair
varies from 2% to 21%, depending on the extent of the
descending thoracic aorta replacement.25-29 In conven-
tional surgery, much effort is directed to preserving inter-
costal arterial inflow by reattachment of these vessels, in
particular those between the T8 and T12 level. A variety of
diagnostic and therapeutic adjunctive methods have been
used, including cerebrospinal fluid (CSF) drainage, to re-
duce the arterial-cerebrospinal fluid gradient.27,30-33 De-
spite the large choice in available options to prevent SCI,
neurologic deficit remains a considerable threat in open
repairs.29
The introduction of endovascular techniques as an
alternative option for the treatment of thoracic aortic dis-
Table IV. Multivariate regression analysis for paraplegia
Risk factor
P value,
paraplegia
(n  15) OR (95% CI)
Degenerative aneurysm .1406 2.75 (.72-10.6)
Localization disease at proximal,
middle, and descending
thoracic aorta
.4866 .54 (.10-3.03)
Number of stent grafts 3 .0428 3.49 (1.04-11.7)
Left subclavian artery covering
without transposition/bypass
.0274 3.94 (1.17-13.3)
Occlusion by device T10 .2474 2.07 (.60-7.11)
Renal failure (score 1)* .0215 3.63 (1.21-10.9)
Concomitant open abdominal
surgery
.0371 5.52 (1.11-27.5)
OR, Odds ratio; CI, confidence interval; NS, not significant.
*Society for Vascular Surgery/American Association for Vascular Surgery
risk classification.
Table V. Multivariate regression analysis for stroke
Risk factor
P value, stroke
(n  19) OR (95% CI)
Degenerative aneurysm .4626 .65 (.20-2.04)
Proximal into arch or
ascending aorta
.7760 1.20 (.34-4.26)
Duration of procedure 2 h
40 min
.0134 5.25 (1.41-19.6)
Left subclavian artery covering
without
transposition/bypass
.4782 1.58 (.44-5.65)
Female sex .0395 2.95 (1.05-8.26)
Maximum diameter aneurysm .7924 1.00 (.98-9.02)
Age .0937 1.05 (.99-1.11)
OR, Odds ratio; CI, confidence interval; NS, not significant.ease gave rise to some optimism in that the risk of paraple-gia seemed reduced somewhere in the range of 0% to
6%.5,7,8,10,13,14,34 Avoidance of thoracic aortic clamping
and prolonged episodes of hypotension most likely account
for a lower incidence of spinal ischemic symptoms.
Only two studies have compared the incidence of SCI
directly with a control group undergoing open surgery.
The first study observed an insignificantly lower rate of
perioperative paraplegia of 6.7% in the endovascular and
8.6% in the open surgical group.18 The second study dem-
onstrated a statistically lower SCI incidence in patients
treated by endografts (3% vs 14%).35
A number of studies have analyzed which factors in-
crease the risk of SCI after endograft treatment.7,8,18,36,37
Simultaneous or previous open infrarenal aortic replace-
ment has been recognized as a factor associated with a
higher incidence of paraplegia.5,8,9,36 Our multivariate
analysis demonstrated this variable as an independent risk
factor for SCI. The EUROSTAR registry only recorded
data on concomitant infrarenal aortic replacement, and no
conclusions could be drawn about whether previous ab-
dominal aortic repair is associated with similar risks.
It has recently been documented that a compromised
hypogastric artery inflow constituted a significant risk factor
for SCI.38 Some authors suggest that patients with com-
bined aneurysmatic disease of the thoracic and abdominal
aorta be treated with staged procedures to better allow a
gradual development of collateral spinal cord blood flow
from lumbar and hypogastric arteries.8,37
Extensive covering of the thoracic aorta by stent grafts
also presents an increased risk for SCI, as was first docu-
mented by Greenberg et al7 and confirmed by several other
studies.8,20,21 The present series demonstrated that the
number of stent grafts used per patient correlated with
development of paraplegia at univariate and multivariate
analysis. The number of stent grafts per patient clearly
corresponds with the covered aortic length; therefore, our
observation seems in agreement with the previous observa-
tions on the importance of the covered aortic length.
Clinical studies of surgical thoracic and thoracoab-
dominal aneurysm repairs have documented a significant
correlation of renal function and SCI injury.26 The under-
lying metabolic mechanism is not exactly known; however,
renal failure may reflect more advanced peripheral athero-
sclerosis, including intercostal arteries and collaterals to the
spinal cord. The present analysis also indicates renal failure
(Society for Vascular Surgery/International Society for
Cardiovascular Surgery class 1) as an independent risk
factor for SCI. Other previously observed risk factors for
paraplegia after open thoracic aorta surgery included symp-
tomatic disease or rupture of the aorta and perioperative
hypotensive episodes. Perioperative blood pressure data
were not available in the present series; however, Chiesa
et al37 reported in 2004 that a lowest mean arterial blood
pressure of70mmHg presented a significant predictor of
SCI.37
Although many of the risk factors discussed here are
difficult to modify, some precautions can be taken. Caution
is warranted with the continuation of antihypertensive
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aortic disease. Postoperatively, these medications may lead
to episodes of hypotension that sometimes is difficult to
treat. In practice, many physicians involved in the manage-
ment of thoracic aortic disease now frequently (particularly
in patients presenting with risk factors for SCI) reduce or
withhold any antihypertensive medication before endovas-
cular treatment, with the exception of -blockers.
The role of CSF drainage is less well documented in
endovascular than in open repair of thoracic aorta disease.
Many experts, however, advise the selective use of prophy-
lactic CSF drainage in cases requiring coverage of long
segments of thoracic aorta, in particular when the territory
distally of T10 is involved.8,18,37 These patients may be
more vulnerable to postoperative hypotension and so-
called delayed paraplegia. Our data set had no information
on whether paraplegia presented immediately or delayed
after the procedure and whether CSF drainage was used.
The role of unimpeded flow into the left subclavian and
its first branch, the vertebral artery as supplier of the ante-
rior spinal artery, appeared of considerable importance,
because occlusion of the LSA was associated with an almost
fourfold increased incidence of paraplegia. Another less
well recognized collateral source of spinal cord blood sup-
ply is the internal mammary artery and its anterior intercos-
tal branches. This pathway becomes also compromised by
LSA overlapping. When thoracic aortic disease is localized
near the LSA, the surgeon has to decide whether the origin
of this vessel can be covered by the stent graft fabric or will
need a revascularization by subclavian-carotid transposition
or bypass.39-43
Most authors seem to agree that the LSA can be
overstented in most cases, and suggest that preoperative
computed tomography (CT), magnetic resonance imaging
(MRI), or angiography may be helpful in selecting candi-
dates for adjunct LSA revascularization.40,41,43 These as-
sessments should provide information about whether the
left vertebral artery is a dominant source of collateral flow to
the anterior spinal and basilar arteries and identify any
acquired disease or congenital anomalies of the supra-
aortic, vertebral, and internal mammary vessels that pre-
clude safe occlusion of the LSA.
Few data, however, are available on the association of
occlusion of the LSA and the rate of paraplegia. In a 2006
publication, Peterson et al44 reported a review of the liter-
ature on the outcome of subclavian artery covering during
thoracic stent grafting in 218 patients, of whom 114 were
treated by a subclavian artery transposition. The mean
incidence of paraplegia in patients with covered LSA in this
review was 1%, which was lower than the 5% in our study. It
must be noted that in patients with LSA overlap, this vessel
was revascularized in 52% in the compilation of series from
the literature by Peterson et al compared with only 25% in
the current EUROSTAR series. This may reflect that many
surgeons considered the covering of the LSA origin as an
innocuous detail.
Most of the patients with SCI had several risk factors for
a compromised spinal cord perfusion, and loss of collateralflow from the subclavian vertebral system contributed to
the event. The best treatment in the patient with a short
proximal landing zone to the LSA should be selected on the
basis of high-quality imaging of the supra-aortic vessels to
ascertain a functional collateral connection between the
right-sided vertebral and mammary arteries and the spinal
cord circulation. In our experience, many preoperative CT
or MRI studies do not provide this kind of detailed infor-
mation.
It should be recognized that LSA transposition is a
low-risk procedure. Simply ignoring the LSA take off and
occluding it by the stent graft seems no longer appropriate
in most patients considering the data reported here. Op-
tions to maintain the perfusion of supra-aortic branches
with fenestrated devices or retrograde stent deployment
through the device are presently being developed.45,46
The incidence of stroke, similar to SCI, varies widely. In
a review of the literature reported in 2006, an intracranial
stroke developed in average of 2.2% of patients undergoing
thoracic aortic endograft treatment,10 which is in agree-
ment with the 3% observed in the present study. The
location of the cerebral infarctions after thoracic endograft-
ing suggests multiple emboli to the anterior or posterior
circulation. These emboli are most likely caused by cathe-
ter, guidewire, or endoprosthesis manipulation in a dis-
eased arch. Other potential etiologic factors for stroke
include air embolism, cervical carotid, and vertebral-basilar
atherosclerotic disease.
A significant risk factor for stroke in our study was a
duration of the procedure 2.6 hours. A longer endovas-
cular procedurewill inevitably be associatedwithmoremanip-
ulation of catheters, guidewires, and introducer systems. The
second factor correlating with an increased stroke risk was
female sex. Evidence is growing that female sex has an adverse
influence on treatment outcomes of aortic aneurysms.47 The
higher complication rate in women has been attributed to
more advanced atherosclerosis as well as to smaller diameter
peripheral arteries.
Precautions to prevent cerebral embolism include care-
ful preinterventional planning to reduce procedural time. A
poor quality arch with mural thrombus can be identified
best by transesophageal echography. Five of 19 stroke
patients (26%) in this EUROSTAR series had LSA occlu-
sion without revascularization, which did not present a
significant correlation. In other studies,19 however, this
variable correlated statistically with the risk of stroke; there-
fore, similar vascular anatomic criteria to perform a LSA
transposition to prevent SCImay also apply in perioperative
stroke prevention.
CONCLUSIONS
Severe neurologic complications are not rare after en-
dovascular thoracic aortic procedures. The combined inci-
dence of stroke and paraplegia was 5% in the current series.
Risk factors for both complications were identified, and
strategies for modification of these variables were discussed.
The perhaps the most important precaution that emerged
from this study involved the revascularization of the LSA in
JOURNAL OF VASCULAR SURGERY
Volume 46, Number 6 Buth et al 1109patients who need incorporation of the origin of this vessel
in the proximal landing zone of the stent graft. In this
series, neurologic complications were only observed in
patients in whom prophylactic rerouting of the blood flow
had not been performed, and 8.4% of this category had a
severe neurologic event (stroke or paraplegia) compared
with 0% in patients with revascularization of the LSA. To
properly select patients for subclavian revascularization
considerable expertise with imaging of this vascular terri-
tory is required. If after careful CT, MRI, or angiography,
or a combination of these, there still is doubt about the
collateral supply of the spinal cord, a left subclavian–carotid
transposition may be the safest option.
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Dr Richard Cambria (Boston, MA): Dr Buth, thanks for
bringing to our Society yet another chapter from the EUROSTAR
database.
Your report seems to echo a recent review assembled by Mark
Morasch and his colleagues from Northwestern and published in
the JVS within the last year, calling attention to the fact that
perhaps a cavalier attitude towards left subclavian artery coverage is
inappropriate. And in the Tag 9901 study, Dr Mike Makaroun
pointed out that left subclavian artery coverage seemed to be an
increased risk factor for stroke, not paraplegia, perhaps being a
surrogate for manipulation of stent grafts in the arch.
I have a few questions, and thank you for giving me a copy of
the manuscript, it certainly is exhaustively detailed. Did you ana-
lyze the risk of paraplegia as a function of pathology, dissection
versus degenerative aneurysm, and the clinical circumstances of the
procedure, urgent procedure versus elective procedure? Also, the
overall rates of both paraplegia and stroke in this registry are
admirably low. Just about 25minutes ago I showed a series of stent
grafts, all in urgent cases, but with a stroke rate of 10%. And
indeed, in our own 250 cases, that figure is 9%; so I think the
overall results in this study are in fact excellent.
I presume, and it is in your conclusion, you are prepared to
recommend that cavalier left subclavian artery coverage is no
longer appropriate?
Dr Jacob Buth: Starting with your last comment. Yes, I
certainly recommend to revascularize in most instances the left
subclavian artery unless the preoperative imaging is impeccable and
indicates clearly collateral communications with the spinal cord.
The imaging in our experience is often not conclusive.
With regard to the previous articles that you mentioned, Dr
Morasch had an increased incidence of complications because of
left subclavian artery, because there are many other complications
that may occur by covering this artery. I remember he more often
observed endoleakage or arm complications, not so frequently
paraplegia.
Dr Makaroun found that stroke significantly correlated with
LSA covering. In the current study, this comparison just did not
make the level of statistical significance. However, if we combined
stroke and spinal cord ischemia, this rate was statistically signifi-
cantly higher in the group with a non-revascularized left subclavianRegarding your first comments, degenerative aneurysms had
2.5 times as frequent paraplegia than other thoracic disease, i.e.
3.7% compared to a 1.5% rate of paraplegia. This difference was not
statistically significant.
Dr Roy Greenberg (Cleveland, Ohio): Dr Buth, I also want
to thank you for a copy of the manuscript ahead of time, and I
enjoyed the presentation. I had a couple of questions regarding
your analysis, and I was a little bit surprised (or confused) as to how
the proximity of the aneurysm to the subclavian was not significant,
while the need for subclavian artery coverage was significant. Is
there another reason to cover the subclavian besides aneurysmal
involvement? I had believed the two entities to be inexorably
linked.
The other question falls back on Dr Cambria’s question,
which would be to clarify the message we should take from the
paper. The EUROSTAR database involves a broad range of insti-
tutions, and nonconsecutive patient enrollment with a variety of
diseases and other issues that come into play. Should we now
universally recommend preoperative carotid subclavian bypass? Are
there specific factors that you can tell us where we should be doing
that and specific times when we don’t need to?
Dr Buth: Regarding the fact that we did not find a correlation
between SCI and the localization of the disease and the LSA, this
distance it was not measured as such. It was represented rather as a
thoracic aorta segment. Thus, we had no accurate information of
the localization of the lesion in relation to the left subclavian artery.
This clearly is the reason that that was not a significant factor, while
the covering itself was a significant factor for the development of
neurologic complications.
With regard to the management recommendation based on
our observations, I would think that we still have to learn more
about vertebral artery imaging. In particular, how are the collater-
als to the anterior spinal artery, which is the dominant side of
supply, and how is the anatomy of the basilar artery of the circle of
Willis. Sometimes one encounters an unexpected case of paraple-
gia. For example in a recent report, a patient with a traumatic tear
of the thoracic aorta was described. This patient had a covering of
the left subclavian artery and paraplegia developed quite unexpect-
edly. I know of other similar cases. I think that imaging of the
collateral communication between the vertebral artery and the
spinal cord often is imperfect.
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tion. I have two questions: One, when the strokes occurred, which
hemispheres did it involve? Two, what is your philosophy regard-
ing spinal protection. We always use CSF drainage and pharmaco-
logical protection. Did you analyze data pertaining to adjuncts for
CSF protection? Thank you.
Dr Buth: The localization and the type of intercranial stroke
(ie, whether anterior and posterior strokes were observed) could
not accurately be retrieved from our data; similarly for left and right
strokes. From what we could find and from previous reports, weknow that there is not a straightforward correlation. So strokes are
not always in the left anterior territory.
With regard to spinal cord protection, I can only quote from
the literature because there was very little information on used
methods of protection or on the late spinal cord ischemia in the
current series in the registry’s case record form. Protection mea-
sures in TEVAR [thoracic endovascular aneurysm repair] usually
are based on what is customary and what is known to be effective in
open thoracic aorta repair. Frequently spinal fluid drainage is used.
In reality, we don’t know exactly whether it is really necessary.INVITED COMMENTARYTimothy A.M Chuter, San Francisco, Calif
The main strength of the accompanying study is its size. Even
though the study group included two very different diseases,
aneurysm and dissection, the numbers were still large enough to
demonstrate significant variations in the rates of relatively rare
neurologic complications. It appears that repeatedly instrumenting
a diseased ascending aorta or arch in an elderly patient raises the
risk of stroke, and occluding the left subclavian artery, isolating a
long segment of aneurysmal thoracic aorta, and simultaneously
repairing an abdominal aortic aneurysm (AAA) raises the risk of
paraplegia. Admittedly, these conclusions rest on slightly tenuous
assumptions. For example, the duration of the procedure was a
surrogate for the extent of aortic instrumentation, and the number
of stent grafts was a surrogate for the length of the covered
segment. Nevertheless, the findings make sense and they agree
with the findings of other studies.
In general, there are two ways to respond to this kind of
information: change the procedure, or change the selection crite-
ria. The current study indicates several risk factors for stroke that
affect patient selection but not the conduct of the operation. All
the possible procedural modifications relate to the risk of paraple-bypass was quite modest, collateral flow through branches of the
left subclavian artery may be more critical in patients who have
other reasons for spinal arterial compromise. The same may be said
of cerebrospinal fluid drainage, which has been shown in studies of
open repair to have a spinal protective effect. The risks of simulta-
neous AAA repair have been noted before, but whether staging the
operation would prevent paraplegia depends on the relative impor-
tance of hemodynamic instability, lumbar artery occlusion, and
collateral development between stages.
Despite many publications on this subject, the occurrence of
paraplegia remains a largely random event owing to the effects of
currently unidentified risk factors. Some of this uncertainty may
yield to new methods of imaging the spinal blood supply. Prelim-
inary findings suggest that the source of spinal perfusion may be a
strong predictor of paraplegia risk after open repair. The current
study suggests that collateral pathways may be equally important.
Imaging studies and other more direct measurements may also
strengthen the analysis by providing a continuous variable, such as
spinal perfusion, oxygenation, or metabolism, as an alternative togia. Although, the overall protective effect of carotid–subclavian the current dichotomous outcome.
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European Collaborators on Stent/Graft Techniques
for Aortic Aneurysm Repair (EUROSTAR) collaborative
centers that contributed their data for this study.
Belgium: Aalst, Onze Lieve VrouweHospital; Antwer-
pen, Hospital Middelheim, University Hospital, Monica
Hospital/OLV/Eeuwfeestkliniek; St Augustinus Hospital;
Arlon, Clinique St Joseph; Assebroek, Hospital St Lucas/
St Jozef; Bonheiden, Imelda Hospital; Brugge, Hospital St
Jan; Brussels, Hospital Erasme, Free University Hospital,
Clinique de l’Europe St Michel, University Hospital St
Luc, and Clinique Saint Jean; Charleroi, University Hospi-
tal; Dendermonde, Hospital St Blasius; Genk, St Jan Hos-
pital; Gent, University Hospital and Hospital Maria Mid-
delares - St Jozef; Gilly, St Joseph Hospital; Haint Saint
Paul, Hospital de Jolimont; Hasselt, Virga Jesse Hospital;
La Louvière, Central Hospital de Tivoli; Leuven, Univer-
sity Hospital; Liège, University Hospital; Mont Godinne,
Hospital de Mont Godinne; Mouscron, Central Hospital;
Namur, Central Hospital Regional and Hospital St Elisa-
beth; Roeselare, Heilig Hart Hospital; St Truiden, St
Trudo Hospital; Tongeren, Hospital Vesalius; Turnhout,
St Josef Hospital; and Vilvoorde, St Josef Hospital.
Germany: Frankfurt, City Hospital; Hamburg, Altona
General Hospital; Leipzig, Park-Hospital; München, City
Hospital; Oldenburg, Pius Hospital.
Ireland: Dublin, St James Hospital.
Italy: Roma, Hospital San Giovanni.
TheNetherlands:Amsterdam,AcademicMedical Centre
and Onze Lieve Vrouwe Hospital; Eindhoven, Catharina
Hospital; Enschede, Medisch Spectrum Twente; Groningen;
University Hospital; Rotterdam, Dijkzicht Hospital.
Norway: Trondheim, University Hospital.
Spain: Barcelona, University Hospital; Madrid, Hospi-
tal Ramon y Cajal; Malaga, HR Carlos Haya; Valladolid,
Hospital Valladolid.
Sweden: Örebro, Medical Centre.
Switzerland: Lugano, Cardiocentra Ticino.
United Kingdom: Bournemouth, Royal Hospital; Le-
icester, Royal Infirmary; Liverpool, Royal University Hos-
pital; New Castle-Upon-Tyne, Freeman Hospital.
Appendix 2 (online only). General outcome events
Methods
Primary technical success was defined as complete ex-
clusion of the aneurysm or coverage of the proximal entry
tear in aortic dissection and absence of primary endoleak or
significant endoluminal graft stenosis. Findings at follow-up
visits, which involved clinical examination, computed tomog-
raphy (CT), occasionally angiography,magnetic resonance im-
aging, or transesophageal echocardiography, were re-
corded. Patients were followed up at 1, 6, and 12 months,
and annually thereafter. The mean follow-up of the entire
patient cohort was 14.1 months and of first-month survi-
vors, 15.5 months (range, 1 to 72 months). Satisfactory
findings at CT were defined by absence of endoleak, stent
graft migration, and aneurysm expansion. In case of dissec-tion, additional criteria included complete thrombosis of
the false lumen and, in extensive dissection, thrombosis of
the treated proximal segment of the dissection (partial false
lumen thrombosis).
Results
The device label did not make a difference for the
incidence of neurologic events. Technical success of the
stent graft procedure was observed in all 15 patients (100%)
with spinal cord ischemia (SCI), in 16 patients (84%) with
stroke, and in 515 of the patients (90%) in the control
group, which rates were comparable. Device-related com-
plications occurred more frequently in patients with post-
operative stroke: four patients (21%) vs in 39 of controls
(6.8%; OR, 3.66; 95% CI, 1.16 to 11.55; P  .018).
Systemic complications occurred more frequently in
patients with SCI and with stroke: 8 patients (53%) and 12
(63%), respectively, vs 112 patients (19.8%) in controls
(stroke: OR, 6.96; 95% CI, 2.68 to 18.09; P .0001; SCI:
OR, 4.64; 95% CI, 1.65 to 13.07; P  .0015).
Duration of the stay at the intensive care unit (ICU)
and hospital admission time lasted at least twice as long in
the SCI and stroke groups compared with controls: 189
and 132 hours vs 99 hours, and 21 and 23 days vs 10.4
days, respectively (for ICU stay dichotomized at 120
hours, P .003 and P 0.001 for SCI and stroke patients
vs controls respectively; and for hospital admission dichot-
omized 14 days, P  .0006 and P  .002 for SCI and
stroke patients vs controls, respectively).
The incidence of endoleaks at completion angiography
was 9.4%. and at 30 days, 6.8%. There were no differences
between the subgroups.
The 30-day mortality in the entire cohort was 9.9%.
There were no significant differences between the different
etiologic categories: degenerative aneurysm, 10.7%; dissec-
tion, 9.3%; traumatic injury, 9.0%; false anastomotic aneu-
rysm, 12%; and other causes, 0%. The 30-day mortality in
patients receiving elective treatment was 5.3% compared
with 19% in acute operations (OR, 4.35; 95% CI, 2.47 to
7.68; P  .0001). The 30-day mortality included six pa-
tients (40%) in the SCI group, seven (37%) in the stroke
group, and 49 (8.5%) in the control group (SCI: OR, 7.14;
95% CI, 2.44 to 20.90; P  .0001; stroke: OR, 6.25; 95%
CI, 2.35 to 16.60; P  .0001). Conversion to open repair
occurred in 12 patients (2%) in the entire cohort. No
conversions were required in the category with neurologic
complications.
The 12-month rates for endoleak were 15.2%, device
migration, 0.5%; need for secondary intervention, 10.9%;
and aneurysmal expansion 7 mm, 7.7%. The cumulative
survival after 1 year in patients with SCI and stroke was 25%
and 40%, respectively; in comparison, respective the 1- and
2-year survival in controls was 88.9% and 87.2%, (Appendix
2 Fig, online only). The greatest mortality was in the first
month, with the respective survival in the SCI and stroke
groups of 50% and 60.3%.
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Most vascular specialists currently believe endovascular
treatment of thoracic aortic disease to be superior to con-
ventional surgery. In recently published series, including
patients with different aortic pathologies, combining elec-
tive and emergency procedures, the perioperative mortalityin elective patients and 9.9% in the entire current
EUROSTAR series was in agreement with these previous
series. Other outcome measures at follow-up included
1-year rates of secondary procedures in 11%, endoleaks in
15%, device migration in 0.5% and stable or shrinking
aneurysms in 92%. These figures are also in concordancewas 2% to 10%.13-21 An observed 30-day mortality of 5.3% with other published experience.15,22-24
Appendix 2 Fig (online only). Overall survival during follow-up in patients with paraplegia, stroke, and other pa-
tients.
